Daniela Brunner

About Daniela Brunner

Daniela Brunner, PhD is the CIO and CTO of PsychoGenics Inc, a biotech working on the development of novel technologies and drug therapies using AI. She is a member of the Business Advisory Board of the Children\'s Tumor Foundation and the Scientific Advisory Board of Cure VCP Disease. Dr. Brunner has worked on the validation of preclinical models of developmental, psychiatric and neurodegenerative disease models for the last 20 years. A major focus of her work has been the development of AI-based high throughput platforms for analysis of behavioral data, using machine learning algorithms to comb behavioral signatures for phenotyping, drug screening, and treatment response in both the preclinical and clinical domains.

Experience

1. Chief Technology Officer

   PsychoGenics

   Nov 2023 — Present · NJ, US

Education

• University of Cambridge

  PhD, Experimental Psychology

  1987 — 1990

• Columbia University

  Post-Doc, Neuroscience

  1990 — 1996

• Colegio Nacional de Buenos Aires

  High School Diploma, -

  1973 — 1976

• University of Buenos Aires

  Master of Science (MS), Physiology of Behavior

  1978 — 1984

Skills

• Biotechnology
• Research and Development (R&D)
• Experimentation
• R&D
• Drug Development
• Scientific Writing
• Data Analysis
• Statistics
• Biology
• Animal Models
• Science
• Biochemistry
• In Vivo
• Behavior
• Cognitive Neuroscience
• Translational Research
• Drug Discovery
• Experimental Design
• Lifesciences
• Research
• Pharmaceutical Industry
• Neuropharmacology
• Neuroscience
• Life Sciences
• Behavioral Neuroscience
• Pharmacology